Study guide
12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus
Combined Medical Services Examination UPSC CMS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Logistics & Pattern
1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths
2 Chapter 2: General Medicine - Cardiology & Respiratory
2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism
3 Chapter 3: General Medicine - Gastroenterology & Hepatology
3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes
4 Chapter 4: General Medicine - Nephrology & Endocrinology
4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction
5 Chapter 5: General Medicine - Neurology, Haematology & Infection
5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue
6 Chapter 6: General Medicine - Emergency Medicine & Toxicology
6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology
7 Chapter 7: Paediatrics - Neonatology & Child Growth
7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones
8 Chapter 8: Paediatrics - Child Health & Nutrition
8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning
9 Chapter 9: Surgery - General Surgery, Wounds & Shock
9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery
10 Chapter 10: Surgery - Surgical Specialties I
10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi
11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia
11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease
12 Chapter 12: Obstetrics - Antenatal Care & Complications
12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management
13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH
13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care
14 Chapter 14: Gynaecology & Family Planning
14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods
15 Chapter 15: PSM - Epidemiology & Biostatistics
15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing
16 Chapter 16: PSM - Disease Epidemiology & Programmes
16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling
17 Chapter 17: PSM - Health Planning & Environmental Health
17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education
12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus
Key Takeaways Explain This Topic AI
Anemia in pregnancy is defined as Hb <11.0 g/dL (WHO/ICMR); iron deficiency anemia is the predominant cause, showing microcytic hypochromic RBCs and serum ferritin <30 ng/mL.
Parenteral iron dosage is calculated using the Ganzoni formula: Total Iron Deficit (mg) = Weight (kg) × (Target Hb - Actual Hb) × 2.4 + 500 mg.
DIPSI criteria diagnoses Gestational Diabetes Mellitus (GDM) using a single-step 75 g oral glucose test regardless of fasting status, with a 2-hour plasma glucose threshold of ≥140 mg/dL.
Uncontrolled GDM causes maternal polyhydramnios and preeclampsia, and fetal macrosomia, shoulder dystocia, neonatal hypoglycemia, and respiratory distress syndrome.
Insulin is the first-line pharmacotherapy for GDM when medical nutrition therapy fails to achieve fasting glucose <95 mg/dL or 2-hour postprandial glucose <120 mg/dL.
Last updated: July 2026
12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus
Medical disorders complicating pregnancy contribute substantially to indirect maternal mortality and long-term perinatal morbidity. Anemia and Gestational Diabetes Mellitus (GDM) represent the two most common medical conditions encountered in obstetric practice in India.
- 1. Anemia in Pregnancy
- Physiological Anemia of Pregnancy
During pregnancy, maternal plasma volume expands by 40–50% , whereas red blood cell (RBC) mass increases by only 20–30% . This disproportionate hemodilution results in a physiological drop in hemoglobin concentration and hematocrit, reaching its nadir at 28–32 weeks of gestation.
Diagnostic Cut-offs & Severity Grading
WHO Diagnostic Criterion: Hemoglobin (Hb) < 11.0 g/dL < 11.0\text{ g/dL} < 11.0 g/dL (or Hematocrit < 33 % < 33\% < 33% ) in the 1st and 3rd trimesters, and < 10.5 g/dL < 10.5\text{ g/dL} < 10.5 g/dL in the 2nd trimester.
ICMR / Anemia Mukt Bharat Severity Grading:
- Mild Anemia: Hb 10.0 – 10.9 g/dL
- Moderate Anemia: Hb 7.0 – 9.9 g/dL
- Severe Anemia: Hb 4.0 – 6.9 g/dL
Very Severe Anemia: Hb < 4.0 g/dL < 4.0\text{ g/dL} < 4.0 g/dL (high risk of high-output congestive heart failure and maternal mortality!)
Iron Deficiency Anemia (IDA)
Iron Deficiency Anemia accounts for > 85 % > 85\% > 85% of all anemia cases in pregnancy.
Laboratory Evaluation:
Peripheral Blood Smear: Microcytic, hypochromic red cells with anisopoikilocytosis.
Red Cell Indices: Reduced MCV ( < 80 fL < 80\text{ fL} < 80 fL ), reduced MCH ( < 27 pg < 27\text{ pg} < 27 pg ), elevated RDW ( > 15 % > 15\% > 15% ).
Serum Ferritin: < 30 ng/mL < 30\text{ ng/mL} < 30 ng/mL (the single most sensitive and specific biochemical marker for early iron deficiency).
Serum Iron & TIBC: Decreased serum iron ( < 60 mcg/dL < 60\text{ mcg/dL} < 60 mcg/dL ), elevated Total Iron Binding Capacity (TIBC > 400 mcg/dL > 400\text{ mcg/dL} > 400 mcg/dL ), transferrin saturation < 16 % < 16\% < 16% .
Treatment Protocols & Iron Dose Calculations
Oral Iron Therapy: Indicated for mild anemia and early moderate anemia ( > 14 weeks > 14\text{ weeks} > 14 weeks ). Administer 100–200 mg elemental iron daily along with 1 mg 1\text{ mg} 1 mg folic acid. Reticulocyte response peaks at 7–10 days; Hb rises by 0.7 – 1.0 g/dL 0.7–1.0\text{ g/dL} 0.7–1.0 g/dL per week.
Parenteral Iron (IV Iron Sucrose / Ferric Carboxymaltose - FCM): Indicated for moderate anemia (Hb 7 – 9.9 g/dL 7–9.9\text{ g/dL} 7–9.9 g/dL ) beyond 16–24 weeks, oral iron intolerance, severe non-compliance, or malabsorption.
Ganzoni Formula for Total Iron Deficit: Total Iron Deficit (mg) = Weight (kg) × ( Target Hb − Actual Hb [ g/dL ] ) × 2.4 + Depot Iron (500 mg) \text{Total Iron Deficit (mg)} = \text{Weight (kg)} \times \left( \text{Target Hb} - \text{Actual Hb} [\text{g/dL}] \right) \times 2.4 + \text{Depot Iron (500 mg)} Total Iron Deficit (mg) = Weight (kg) × ( Target Hb − Actual Hb [ g/dL ] ) × 2.4 + Depot Iron (500 mg)
(Target Hb is typically taken as 11.0 g/dL 11.0\text{ g/dL} 11.0 g/dL or 12.0 g/dL 12.0\text{ g/dL} 12.0 g/dL ) .
3. Blood Transfusion (Packed Red Blood Cells / PRBC):
Indications:
Severe anemia (Hb < 7 g/dL < 7\text{ g/dL} < 7 g/dL ) diagnosed after 36 weeks of gestation (insufficient time for parenteral iron to take effect before labor).
Severe anemia (Hb < 5 g/dL < 5\text{ g/dL} < 5 g/dL ) at any gestational age.
Anemia complicated by cardiac failure, severe infection, or active bleeding.
2. Gestational Diabetes Mellitus (GDM)
Gestational Diabetes Mellitus is defined as carbohydrate intolerance of variable severity with onset or first recognition during pregnancy.
Diabetogenic Pathophysiology of Pregnancy
Pregnancy is a diabetogenic state. The placenta secretes human Placental Lactogen (hPL), Human Placental Growth Hormone, Cortisol, Progesterone, and Prolactin. These hormones act as insulin antagonists , inducing progressive maternal peripheral insulin resistance. Peak insulin resistance occurs between 24 and 28 weeks of gestation.
DIPSI Guidelines for Screening & Diagnosis (Single-Step Test)
The Diabetes in Pregnancy Study Group India (DIPSI) guidelines provide a non-fasting, single-step diagnostic procedure tailored for resource-limited settings:
Procedure: 75 g oral anhydrous glucose dissolved in 300 mL of water is administered to the pregnant woman regardless of the time of her last meal or fasting status .
Timing of Blood Sample: Venous plasma glucose is measured at 2 hours .
- 2-Hour Venous Plasma Glucose (DIPSI) Clinical Diagnostic Category
- < 120 mg/dL < 120\text{ mg/dL} < 120 mg/dL Normal Glucose Tolerance
- 120 – 139 mg/dL Decreased Glucose Tolerance (Gestational Intolerance)
- ≥ 140 mg/dL \ge 140\text{ mg/dL} ≥ 140 mg/dL (7.8 mmol/L) Gestational Diabetes Mellitus (GDM)
- ≥ 200 mg/dL \ge 200\text{ mg/dL} ≥ 200 mg/dL Overt / Pre-gestational Diabetes Mellitus
- WHO / IADPAG 75g OGTT Criteria (Fasting Required)
Alternative 2-hour 75g Oral Glucose Tolerance Test requiring an 8-hour overnight fast:
- Fasting: ≥ 92 mg/dL \ge 92\text{ mg/dL} ≥ 92 mg/dL
- 1-Hour: ≥ 180 mg/dL \ge 180\text{ mg/dL} ≥ 180 mg/dL
2-Hour: ≥ 153 mg/dL \ge 153\text{ mg/dL} ≥ 153 mg/dL (Any ONE abnormal value confirms GDM) .
Maternal, Fetal & Neonatal Complications [Maternal Hyperglycemia] -> [Glucose Crosses Placenta (Insulin Does NOT)]
- |
- v
- [Fetal Hyperglycemia & Hyperinsulinemia]
- |
- +-------------------+------------+------------+-------------------+
- | | | |
- v v v v
- [Fetal Macrosomia] [Inhibition of] [Polycythemia &] [Neonatal]
- (Weight > 4 kg, Surfactant Hyperbilirubinemia [Hypoglycemia]
- Shoulder Dystocia) (Neonatal RDS) (Post-clamping)
Maternal Complications: Pre-eclampsia (2x risk), Polyhydramnios (due to fetal osmotic diuresis), operative delivery (Cesarean section / instrumental), soft tissue trauma, 50% lifetime risk of developing Type 2 Diabetes Mellitus within 10–15 years.
Fetal Complications:
Fetal Macrosomia: Birth weight > 4.0 kg > 4.0\text{ kg} > 4.0 kg or > 90 th > 90^{\text{th}} > 9 0 th percentile (hyperinsulinemia acts as growth hormone).
Shoulder Dystocia: Deposition of fat around fetal shoulders and chest.
Congenital Anomalies: Seen in pre-gestational diabetes (not pure GDM). Caudal Regression Syndrome (Sacral Agenesis) is the most specific anomaly. Cardiac defects (Transposition of Great Arteries, VSD) are most common overall.
Neonatal Complications:
Neonatal Hypoglycemia: Defined as blood glucose < 40 mg/dL < 40\text{ mg/dL} < 40 mg/dL . Sudden cessation of maternal glucose supply at cord clamping while fetal hyperinsulinemia persists.
Respiratory Distress Syndrome (RDS): Fetal hyperinsulinemia inhibits cortisol-mediated synthesis of pulmonary surfactant (dipalmitoylphosphatidylcholine).
Neonatal Hypocalcemia, Hypomagnesemia, Polycythemia, and Hyperbilirubinemia.
Glycemic Targets & Management
Medical Nutrition Therapy (MNT): First-line treatment for 2 weeks. Caloric distribution: 30–35 kcal/kg/day (45–55% complex carbs, 20% protein, 30% fat).
Target Blood Glucose Levels (ACOG / DIPSI):
- Fasting Blood Glucose: < 95 mg/dL < 95\text{ mg/dL} < 95 mg/dL (5.3 mmol/L)
- 1-Hour Postprandial: < 140 mg/dL < 140\text{ mg/dL} < 140 mg/dL (7.8 mmol/L)
- 2-Hour Postprandial: < 120 mg/dL < 120\text{ mg/dL} < 120 mg/dL (6.7 mmol/L)
- HbA1c: < 6.0 % < 6.0\% < 6.0%
Pharmacotherapy: If MNT fails to achieve blood glucose targets after 2 weeks.
Insulin: Gold standard drug of choice. Does not cross the placenta. Total starting dose: 0.7–1.0 U/kg/day.
Metformin: Approved oral alternative if patient refuses insulin or compliance is questionable. Crosses placenta but safe.